Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function

• Status: Completed
• Trial end date: 2008-11-01

Summary

To evaluate the potential effects of artemether- lumefantrine on the auditory function

• Phase: Phase 4

Details

• Lead Sponsor: Novartis
• Treatments: Artemether; Artemether-lumefantrine combination; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Atovaquone, proguanil drug combination; Lumefantrine; Mefloquine; Proguanil